5.0
Jan 24, 2023
Current employee, more than 5 years
Wilmington, DE
Recommend
CEO approval
Business Outlook
Pros
Scientific driven Good collaborative environment Fast pace Great benefits
Cons
Niche market Highly competitive landscape Transitioning from biotech to pharma